Damya Laoui

Finished

ANI359: Defining the cDC-cellular interactome in non-small cell lung carcinoma to unleash their full potential for cancer immunotherapies

Laoui, D. & Allonsius, L.

1/11/23 → 31/10/24

Project: Fundamental

OZR4011: OZR Backup mandate: Defining the tumor-cDC cellular interactome to unleash their full potential for cancer immunotherapies

Laoui, D. & Allonsius, L.

1/11/22 → 31/10/23

Project: Fundamental

IOFACC9B: IOF Accelerator:Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)

Lahoutte, T., Devoogdt, N., Keyaerts, M., Van Ginderachter, J., Laoui, D., Raes, G., Breckpot, K. & Goyvaerts, C.

1/10/22 → 31/03/24

Project: Applied

ANI297: Tumour-derived dendritic cell vaccination as a novel therapy to prevent metastasis and cancer relapse

Laoui, D. & Murgaski, A.

1/01/22 → 31/12/22

Project: Fundamental

VOPPU95: VOPPU95 - Prijs Kankeronderzoek 2020 - Helena Van Damme

Van Ginderachter, J., Laoui, D. & Van Damme, H.

1/01/21 → 30/06/21

Project: Fundamental

FWOTM1009: Deciphering the dendritic cell compartment in ovarian cancer to assess their potential as tumor vaccines

Caro, A. A. & Laoui, D.

1/11/20 → 31/10/24

Project: Fundamental

ANI258: Deciphering the dendritic cell compartment in ovarian cancer to assess their potential as tumor vaccines.

Laoui, D.

1/11/20 → 31/10/21

Project: Fundamental

OZR3751: Bilateral cooperation within the framework of a joint doctoral project: benchfee for joint PhD VUB - KU Leuven, CARO Aarushi Audhut

Laoui, D.

8/10/20 → 7/10/24

Project: Fundamental

OZR3616: Francqui Collen Start-Up Grant: Damya Laoui 2020 - 2023

Laoui, D.

1/09/20 → 31/08/23

Project: Fundamental

ANI255: Francqui Collen Start-Up Grant: Damya Laoui 2020 - 2023

Laoui, D.

1/09/20 → 31/08/23

Project: Fundamental

OZR3588: Financiering FWO hercules: ERA platform: Extended RNA Analysis platform - version 2.0

Rooman, I., Bouwens, L., Heimberg, H., Neyns, B., Vranken, W., Vanhaecke, T., Massie, A., van Grunsven, L., De Bruyne, E., De Bundel, D., Forsyth, R., Breckpot, K., Van Dooren, S., De Kock, J., Njemini, R. & Laoui, D.

1/05/20 → 30/04/24

Project: Fundamental

ANI249: CCR8 blockade for the improvement of immunotherapy in non-small cell lung carcinoma

Van Ginderachter, J., Devoogdt, N., Laoui, D. & Van Damme, H.

1/04/20 → 31/03/24

Project: Fundamental

FWOSB79: A novel cancer therapy that selectively targets tumor-infiltrating regulatory T cells

Van Ginderachter, J., Laoui, D. & Arnouk, S.

1/11/19 → 31/10/23

Project: Fundamental

FWOTM956: cDC2s: new players in the tumor microenvironment

Laoui, D.

1/10/19 → 30/09/22

Project: Fundamental

ANI232: Unraveling the functional B-cell heterogeneity in solid tumors and their impact on cancer immunotherapy

Laoui, D.

1/10/19 → 30/09/20

Project: Fundamental

FWOTM969: Unravelling the functional B-cell heterogeneity in solid tumors and their impact on cancer immunotherapy

Laoui, D. & Bardet, P.

1/10/19 → 31/10/24

Project: Fundamental

FWOSB60: Blockade of the VSIG4 immune checkpoint molecule as novel cancer therapy

Lebegge, E., Van Ginderachter, J. & Laoui, D.

1/01/19 → 31/12/22

Project: Fundamental

FWOKN304: Targeting tumor myeloid cells via combination immunotherapy to enhance the efficacy of therapeutic tumor-derived cDC vaccination strategies

Laoui, D. & Van Ginderachter, J.

1/01/18 → 31/12/18

Project: Fundamental

FWOSB45: Tumor-derived dendritic cell vaccination as novel approach for the prevention of cancer relapse

Van Ginderachter, J., Laoui, D. & Murgaski, A.

1/01/18 → 31/12/21

Project: Fundamental

ANI137: Inflammasome activation and IL-B maturation in distinct tumor-associated macrophage and dendritic cell subsets and their impact on tumor characteristics.

Van Ginderachter, J. & Laoui, D.

1/11/15 → 28/02/19

Project: Fundamental

Damya Laoui

Projects

Search results